Search

Jessica Marie Prince

Examiner (ID: 16878, Phone: (571)270-1821 , Office: P/2486 )

Most Active Art Unit
2486
Art Unit(s)
2482, 2486, 2609, 2485, 2621
Total Applications
857
Issued Applications
606
Pending Applications
80
Abandoned Applications
190

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6938526 [patent_doc_number] => 20050112089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Conjugate of biodegradable aliphatic polyester with TAT 49-57 peptide or peptide chain containing TAT 49-57 peptide and nanoparticle manufactured using the same' [patent_app_type] => utility [patent_app_number] => 11/027967 [patent_app_country] => US [patent_app_date] => 2005-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6629 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20050112089.pdf [firstpage_image] =>[orig_patent_app_number] => 11027967 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/027967
Conjugate of biodegradable aliphatic polyester with TAT 49-57 peptide or peptide chain containing TAT 49-57 peptide and nanoparticle manufactured using the same Jan 2, 2005 Abandoned
Array ( [id] => 7039278 [patent_doc_number] => 20050158712 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'Methods for purifying viral particles for gene therapy' [patent_app_type] => utility [patent_app_number] => 11/016560 [patent_app_country] => US [patent_app_date] => 2004-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10624 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20050158712.pdf [firstpage_image] =>[orig_patent_app_number] => 11016560 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/016560
Methods for purifying viral particles for gene therapy Dec 16, 2004 Abandoned
Array ( [id] => 432151 [patent_doc_number] => 07264924 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-09-04 [patent_title] => 'Methods for detecting bacteriophage MS2' [patent_app_type] => utility [patent_app_number] => 11/010700 [patent_app_country] => US [patent_app_date] => 2004-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7356 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 238 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/264/07264924.pdf [firstpage_image] =>[orig_patent_app_number] => 11010700 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/010700
Methods for detecting bacteriophage MS2 Dec 1, 2004 Issued
Array ( [id] => 428510 [patent_doc_number] => 07267943 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-09-11 [patent_title] => 'Methods for detecting bacteriophage MS2' [patent_app_type] => utility [patent_app_number] => 11/009852 [patent_app_country] => US [patent_app_date] => 2004-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7356 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 238 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/267/07267943.pdf [firstpage_image] =>[orig_patent_app_number] => 11009852 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/009852
Methods for detecting bacteriophage MS2 Dec 1, 2004 Issued
Array ( [id] => 7178254 [patent_doc_number] => 20050123999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-09 [patent_title] => 'Dihydroouabain-like factor and diagnostic & therapeutic compositions and methods' [patent_app_type] => utility [patent_app_number] => 10/988991 [patent_app_country] => US [patent_app_date] => 2004-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13219 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20050123999.pdf [firstpage_image] =>[orig_patent_app_number] => 10988991 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/988991
Dihydroouabain-like factor and diagnostic & therapeutic compositions and methods Nov 14, 2004 Abandoned
Array ( [id] => 7075269 [patent_doc_number] => 20050148537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => 'Immunostimulatory nucleic acid molecules' [patent_app_type] => utility [patent_app_number] => 10/987146 [patent_app_country] => US [patent_app_date] => 2004-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 21785 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20050148537.pdf [firstpage_image] =>[orig_patent_app_number] => 10987146 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/987146
Immunostimulatory nucleic acid molecules Nov 11, 2004 Abandoned
Array ( [id] => 5743118 [patent_doc_number] => 20060088843 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'Modified venom and venom components as anti-retroviral agents' [patent_app_type] => utility [patent_app_number] => 10/883834 [patent_app_country] => US [patent_app_date] => 2004-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10498 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20060088843.pdf [firstpage_image] =>[orig_patent_app_number] => 10883834 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/883834
Modified venom and venom components as anti-retroviral agents Oct 24, 2004 Abandoned
Array ( [id] => 6957952 [patent_doc_number] => 20050214322 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Vaccines containing a saponin and a sterol' [patent_app_type] => utility [patent_app_number] => 10/967395 [patent_app_country] => US [patent_app_date] => 2004-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4903 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20050214322.pdf [firstpage_image] =>[orig_patent_app_number] => 10967395 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/967395
Vaccines containing a saponin and a sterol Oct 17, 2004 Abandoned
Array ( [id] => 5726831 [patent_doc_number] => 20060057591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Method for preventing viral infection' [patent_app_type] => utility [patent_app_number] => 10/940642 [patent_app_country] => US [patent_app_date] => 2004-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9162 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20060057591.pdf [firstpage_image] =>[orig_patent_app_number] => 10940642 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/940642
Method for preventing viral infection Sep 14, 2004 Abandoned
Array ( [id] => 5224713 [patent_doc_number] => 20070253979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-01 [patent_title] => 'Immunogenic Hiv Compositions and Related Methods' [patent_app_type] => utility [patent_app_number] => 10/570177 [patent_app_country] => US [patent_app_date] => 2004-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 16455 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20070253979.pdf [firstpage_image] =>[orig_patent_app_number] => 10570177 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/570177
Immunogenic Hiv Compositions and Related Methods Aug 26, 2004 Abandoned
Array ( [id] => 6918758 [patent_doc_number] => 20050096319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-05 [patent_title] => 'Identification of compounds that inhibit replication of human immunodeficiency virus' [patent_app_type] => utility [patent_app_number] => 10/920831 [patent_app_country] => US [patent_app_date] => 2004-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 57255 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20050096319.pdf [firstpage_image] =>[orig_patent_app_number] => 10920831 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/920831
Identification of compounds that inhibit replication of human immunodeficiency virus Aug 17, 2004 Abandoned
Array ( [id] => 7426688 [patent_doc_number] => 20040265801 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Immunoassays for anti-HCV antibodies' [patent_app_type] => new [patent_app_number] => 10/899715 [patent_app_country] => US [patent_app_date] => 2004-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 21882 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20040265801.pdf [firstpage_image] =>[orig_patent_app_number] => 10899715 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/899715
Immunoassays for anti-HCV antibodies Jul 25, 2004 Issued
Array ( [id] => 111869 [patent_doc_number] => 07713535 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-11 [patent_title] => 'Modulation of immunostimulatory properties by small oligonucleotide-based compounds' [patent_app_type] => utility [patent_app_number] => 10/852598 [patent_app_country] => US [patent_app_date] => 2004-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 40 [patent_no_of_words] => 22176 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/713/07713535.pdf [firstpage_image] =>[orig_patent_app_number] => 10852598 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/852598
Modulation of immunostimulatory properties by small oligonucleotide-based compounds May 23, 2004 Issued
Array ( [id] => 6925392 [patent_doc_number] => 20050238647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Therapeutic uses for MDC and MDC antagonists' [patent_app_type] => utility [patent_app_number] => 10/818952 [patent_app_country] => US [patent_app_date] => 2004-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 39416 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20050238647.pdf [firstpage_image] =>[orig_patent_app_number] => 10818952 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/818952
Therapeutic uses for MDC and MDC antagonists Apr 5, 2004 Abandoned
Array ( [id] => 7383742 [patent_doc_number] => 20040180050 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Inverse skewing of the lymphocyte repertoire for therapy and prevention of disease' [patent_app_type] => new [patent_app_number] => 10/808789 [patent_app_country] => US [patent_app_date] => 2004-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11552 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180050.pdf [firstpage_image] =>[orig_patent_app_number] => 10808789 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/808789
Inverse skewing of the lymphocyte repertoire for therapy and prevention of disease Mar 22, 2004 Abandoned
Array ( [id] => 4999364 [patent_doc_number] => 20070041998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'Use of alum and a th1 immune response inducing adjuvant for enhancing immune responses' [patent_app_type] => utility [patent_app_number] => 10/550820 [patent_app_country] => US [patent_app_date] => 2004-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5088 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20070041998.pdf [firstpage_image] =>[orig_patent_app_number] => 10550820 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/550820
Use of alum and a th1 immune response inducing adjuvant for enhancing immune responses Mar 21, 2004 Abandoned
Array ( [id] => 5624881 [patent_doc_number] => 20060263386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Vaccines' [patent_app_type] => utility [patent_app_number] => 10/550754 [patent_app_country] => US [patent_app_date] => 2004-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10262 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20060263386.pdf [firstpage_image] =>[orig_patent_app_number] => 10550754 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/550754
Vaccines Mar 21, 2004 Issued
Array ( [id] => 5699618 [patent_doc_number] => 20060216302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'Immunological markers' [patent_app_type] => utility [patent_app_number] => 10/547046 [patent_app_country] => US [patent_app_date] => 2004-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17119 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20060216302.pdf [firstpage_image] =>[orig_patent_app_number] => 10547046 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/547046
Immunological markers Feb 26, 2004 Abandoned
Array ( [id] => 7677170 [patent_doc_number] => 20040152656 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Immunomodulatory oligonucleotides' [patent_app_type] => new [patent_app_number] => 10/788191 [patent_app_country] => US [patent_app_date] => 2004-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11312 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20040152656.pdf [firstpage_image] =>[orig_patent_app_number] => 10788191 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/788191
Immunomodulatory oligonucleotides Feb 25, 2004 Abandoned
Array ( [id] => 7672886 [patent_doc_number] => 20040180893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Identification of compounds that inhibit replication of human immunodeficiency virus' [patent_app_type] => new [patent_app_number] => 10/783053 [patent_app_country] => US [patent_app_date] => 2004-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 29301 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180893.pdf [firstpage_image] =>[orig_patent_app_number] => 10783053 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/783053
Identification of compounds that inhibit replication of human immunodeficiency virus Feb 18, 2004 Abandoned
Menu